ALLOGENEIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Tailored transplant doses aim to improve blood cancer outcomes
Disease control Recruiting nowThis study tests a personalized approach to stem cell transplants for adults with blood cancers like leukemia and lymphoma. The chemotherapy and radiation doses are adjusted based on each patient's risk factors to try to improve outcomes. The goal is to see if this tailored plan …
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Could a sweet wipe save kids from deadly infections after stem cell transplants?
Disease control Recruiting nowThis study tests if a special wipe containing xylitol (a natural sweetener) applied inside the mouth twice a day can reduce bloodstream infections from mouth bacteria in children receiving stem cell transplants. About 419 children aged 4 months to 25 years will participate across…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Could a lower dose of a common drug make stem cell transplants safer?
Disease control Recruiting nowThis study is for people with blood cancers who are getting a stem cell transplant from a donor. It tests whether a lower dose of a drug called cyclophosphamide can prevent a serious side effect called graft-versus-host disease (GVHD), where donor cells attack the body. The goal …
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated May 18, 2026 12:02 UTC